• CEO, Tennessee Oncology, PLLC
• Certified in medical oncology and internal medicine
• Specialized in adult malignancies

• Partner, Tennessee Oncology, PLLC
• Chief Medical Officer, SCRI
• Director of Drug Development Unit, SCRI
• Focus on development of investigational agents surrounding phase I and II testing
• Lead physician responsible for overall conduct of clinical research program and business development with SCRI affiliate sites and pharmaceutical partners

Will Fitzgibbon

• Managing Partner of Extension Advisors, LLC, a Nashville, Tennessee-based investment banking and strategic advisory firm with a special emphasis on healthcare 
• Founder, Extension Advisors in 2004 and former Managing Director in the healthcare investment banking group at Jefferies & Company 
• Former partner at J.C. Bradford & Co. with coverage responsibilities including healthcare services, healthcare information technology and pharmaceutical outsourcing
• Member, Board of Directors for Horizon Resource Group and change: healthcare

• Chairman of the Board
• President, HCA Outpatient Services Group
• Administrator of daily operations of HCA’s Outpatient Services Group
• Focus on non-hospital outpatient services and business growth opportunities for all HCA market areas
• Over 25 years of healthcare leadership with HCA

• Executive Vice President and Chief Financial Officer, HCA
• Oversees financial operations of HCA including treasury, government reimbursement, tax, accounting, insurance and risk management, and financial reporting
• Over 25 years financial leadership experience with HCA
• Certified Public Accountant since 1981

• Chief Medical Officer and Senior Vice President of Quality, HCA
• Former Under Secretary of Health for U.S. Department of Veterans Affairs
• Former CEO of Veterans Health Administration, the nation’s largest integrated health system

• Executive Director of the Office of Human Research, University of Pennsylvania School of Medicine
• Specialty in clinical research and drug development with focus in clinical trial operations and human research regulations
• Experience in sponsor and CRO enrollments

Cynthia Schwalm, MBA

• Senior Vice President of International Operations with Optimer Pharmaceuticals
• Former President of Eisai Pharmaceuticals, Inc., the U.S. commercial arm of Tokyo-based Eisai Co., LTD.
• Former Vice President and General Manager of the U.S. oncology business at Amgen Inc.
• 30 years of experience in hospital and biotechnology markets in fields of pharmaceuticals, biotechnology, medical devices and healthcare delivery
• New Jersey’s Top 50 Women in Business by NJ Biz in 2009
• Member, Board of Directors for Beth Abrahams Family Services, NYC.

• Chief Executive Officer, SCRI
• Over 20 years healthcare leadership experience
• Founder of SiteWorks Solutions, a leading provider of web-based management systems for clinical trials industry
• Co-Founder of Summit Research Solutions, a multi-specialty site management organization